PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,651 stories, page 621 of 745

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Hong Kong draws royalties giant as mainland China biotech licensing heats up

South China Morning PostOriginal source
🇯🇵Industrysumitomo-pharma.comTier 1 · Company source

Consolidated Financial Statements for Years ended March 31, 2026 and 2025

Sumitomo PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (NASDAQ: LEGN) CEO disposes shares to cover RSU tax

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Does Recursion (RXRX) Russell Value Index Lift Recast Its AI Biotech Story as Deep Value?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Evaluating Oral BTK Inhibitor Remibrutinib in Phase 3 Study for Generalized Myasthenia Gravis: The RELIEVE Trial

NeurologyLiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Compound pharmacies are outrunning regulations. Experts want tougher oversight.

Houston ChronicleOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

[Contribution] From ownership to connection: What BIO USA says about the next 50 years of biotech

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Laplace Announces FDA IDE Approval of TRIUMPH Pivotal Trial of Its Transcatheter Tricuspid Valve Replacement System

The Malaysian ReserveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Abivax reports phase 3 ulcerative colitis trial results By Investing.com

Investing.com AustraliaOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Proposed Collection; 30-Day Comment Request; NIH Information Collection Forms to Support the Genetic Testing Registry (OD)

In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for publi...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

World Trade Center Health Program; Petitions 024, 042, 046, 047, 051, 056, 058, and 067-Ischemic Heart Disease; Finding of Insufficient Evidence

The Administrator of the World Trade Center Health Program received eight petitions (Petitions 024,...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Office of the Director, National Institutes of Health; Notice of Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Importer of Controlled Substances Application: United States Pharmacopeial Convention

United States Pharmacopeial Convention has applied to be registered as an importer of basic class(es...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Importer of Controlled Substances Application: Veterans Pharmaceuticals, Inc.

Veterans Pharmaceuticals, Inc. has applied to be registered as an importer of basic class(es) of con...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.

Veranova, L.P. has applied to be registered as a bulk manufacturer of basic class(es) of controlled...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Importer of Controlled Substances Application: Almac Clinical Services Incorp. (ACSI)

Almac Clinical Services Incorp. (ACSI) has applied to be registered as an importer of basic class(es...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC

Catalent Pharma Solutions, LLC has applied to be registered as an importer of basic class(es) of con...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Statement of Organization, Functions, and Delegations of Authority

This notice sets forth the Statement of Organization of the Office for Civil Rights of the U.S. Depa...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of Oxygenation

The Food and Drug Administration (FDA) is classifying the monitor for opioid induced impairment of o...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of Hyperhidrosis

The Food and Drug Administration (FDA) is classifying the skin patch for treatment of hyperhidrosis...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Submission for Office of Management and Budget Review; Adoption and Foster Care Analysis and Reporting System (AFCARS)

The Administration for Children and Families (ACF) is requesting a revision of the Adoption and Fost...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Center for Scientific Review; Notice of Closed Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities: Submission for OMB Review; Comment Request

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Privacy Act of 1974; Matching Program

In accordance with the Privacy Act of 1974, as amended, the Department of Health and Human Services...

Federal RegisterOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Lenvima

Official structured record identifier: f4bedd21-efde-44c6-9d9c-b48b78d7ed1e.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: LEQEMBI

Official structured record identifier: 9d1ff786-e577-410a-a273-c4d7d0e4e975.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Childrens Fluticasone Propionate ALLERGY RELIEF

Official structured record identifier: 9aaa30cf-1e3b-4382-91dc-568067a4b0ac.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Loperamide Hydrochloride

Official structured record identifier: 52e6ecc5-5f3d-9989-e063-6294a90af2dc.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: NYSTATIN

Official structured record identifier: 50737729-a4a4-e747-e063-6394a90adcc5.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: LISDEXAMFETAMINE DIMESYLATE

Official structured record identifier: 281842ea-d165-4b6d-a366-791239be8c2e.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Losartan Potassium

Official structured record identifier: 25c93638-7016-47d2-a57c-e4a5245ca41b.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Ultra Strength Antacid

Official structured record identifier: 24cec2bc-cf12-b513-e063-6394a90a9447.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Naloxone Hydrochloride

Official structured record identifier: 21d20dff-6efe-481e-a5a0-9c80ded73ca9.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Ibuprofen

Official structured record identifier: 1e6f3ce7-e8a3-40e8-8437-523ef5277b2e.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Lithium Carbonate

Official structured record identifier: 1c320bff-b4d5-42f2-b2b5-238564fe9589.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: escitalopram

Official structured record identifier: 1b2ec266-be5b-9265-e063-6294a90a10e3.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: ENEMEEZ Plus

Official structured record identifier: 1670ca59-7275-4ac6-bef4-674a7b24c7b3.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: unspecified product

Official structured record identifier: 0c2d7295-c0db-448e-bccf-6f2393d8505e.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: ENEMEEZ

Official structured record identifier: 0b06445d-0839-497e-bdff-e0fe224a7738.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Acetaminophen

Official structured record identifier: 08f5742a-7bc8-5786-e063-6294a90a347d.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Degree

Official structured record identifier: 04d81361-885e-cd25-e063-6394a90aa78b.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Topcare Nicotine

Official structured record identifier: 03d9708a-923c-4fd3-ac3d-6ab4a4d8a804.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Finasteride

Official structured record identifier: 03429cec-c6b5-47fe-bb11-6b42f977df7e.

openFDA Drug LabelsOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Nanomaterials for Wound Healing: Mechanisms and Challenges.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

IMPACT-Introduction of Mycotic Prophylaxis At Cystectomy Trial: perioperative mycotic prophylaxis with fluconazole to reduce postoperative complications following cystectomy-study protocol for a national multi-center, double-blinded, placebo-controlled, randomized clinical trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Implementing Project Optimus in Oncology Dosage Optimization: Where are We Now?

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Efficacy, safety, and immunogenicity of an Escherichia coli-produced nine-valent human papillomavirus vaccine: a multicentre, double-blind, randomised, controlled, phase 3 trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

The interplay between gut microbiota and Alzheimer's disease: mechanistic insights from dysbiosis to disease modulation.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Cardiovascular Nanomedicine: Breakthroughs in Therapy-Challenges in Safety and Cardiotoxic Risks: A Comprehensive Review of Inorganic Nanoparticles.

Europe PMCOriginal source
🌍Researchdoi.orgTier 1 · Research record

Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Clinical Research Progress of Acupuncture in the Treatment of Post-Stroke Shoulder-Hand Syndrome

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

The role of baseline PaO2/FiO2, SpO2 and IL-6 indicators in predicting in-hospital mortality in ARDS patients: a retrospective cohort study

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Migration Rates, Clinical and Technical Success for Fixated Compared to Non-Fixated Fully Covered Esophageal Self-Expandable Metal Stents (FCSEMS)

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Alcoholism Research: A Narrative Review

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Clinical evaluation of facial soft-tissue profile using OCTA criteria in patients: A cross-sectional study

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Effect of silver diamine fluoride versus fluoride varnish in arresting early childhood caries: A clinical study

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Clinical and lateral cephalometric evaluation of class II elastic therapy in skeletal class II malocclusion cases indicated for fixed functional appliance: An in vivo study

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Dry Needling Versus Kinesiotaping for Upper Trapezius Trigger Points: A Randomized Controlled Trial

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

PILOT CASE–CONTROL STUDY OF MTHFR C677T AND MTRA2756G POLYMORPHISMS AMONG ALCOHOL/ TOBACCO USERS IN EASTERN UTTAR PRADESH, INDIA (N = 200)

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

STATISTICAL OPTIMIZATION OF AMYLASE PRODUCTION BY BACILLUS WIEDMANNII SPPU 4 USING AGRO-INDUSTRIAL WASTES VIA PLACKETT-BURMAN AND BOX-BEHNKEN DESIGNS

CrossrefOriginal source